TIDMHLMA
RNS Number : 1552R
Halma PLC
25 October 2023
Halma plc ('Halma' or the 'Group')
Acquisitions
Halma, the global group of life-saving technology companies,
today announces that it has completed two bolt-on acquisitions for
an aggregate maximum total consideration of approximately
GBP46.5m.
In the Environmental and Analysis sector, Halma company, Alicat
Scientific, Inc. (Alicat), has acquired the Alpha Instrumatics
Group (Alpha Instrumatics).
Based in Bradford, UK, Alpha Instrumatics designs and
manufactures devices for high-precision measurement of trace
moisture found in gases. Trace moisture analysis allows the safer
operation of industrial equipment, more efficient transfer of
hydrocarbons, and more accurate detection of pollutants. Alpha
Instrumatics' devices are used in growth markets, including the
industrial gas and aerospace markets, as well as industries aligned
to the new energy transition. This acquisition extends Alicat's
product offering in its existing and adjacent end markets.
The initial cash consideration for Alpha Instrumatics is GBP31m,
on a cash- and debt-free basis, which will be funded from Halma's
existing facilities. Additional earn-out considerations are payable
in cash, based on its performance over each of the two financial
years to 31 March 2025, up to an aggregate maximum of GBP5.5m.
Alpha Instrumatics' consolidated unaudited revenue for the 12
months to 30 September 2023 was GBP7.8m, with Return on Sales
substantially above the upper end of Halma's target range of
18-22%.
In the Healthcare sector, Halma company, IZI Medical Products
LLC (IZI), has acquired AprioMed AB (AprioMed). AprioMed designs,
manufactures and distributes medical devices used for bone
biopsies. This acquisition expands IZI's offerings for minimally
invasive procedures, complementing its products used to diagnose
and treat cancer.
The consideration for AprioMed is SEK130m (approximately GBP10m)
on a cash- and debt-free basis, which is funded from Halma's
existing facilities. AprioMed's unaudited revenue for the 12 months
to 31 March 2023 was SEK40.0 (approximately GBP3.0m), with Return
on Sales above Halma's target range of 18-22%.
Marc Ronchetti, Group Chief Executive of Halma, commented:
"Our companies have access to Halma expertise and capital to
support their growth locally and internationally. These bolt-on
acquisitions are strongly aligned with our purpose and financial
model and will bring complementary capabilities to Alicat and IZI
Medical, including new technologies and broader market reach. We
are excited by the opportunities we see for new standalone
companies to join Halma and for our existing companies to add new
capabilities through bolt-on acquisitions to grow their businesses
over the long term."
For further information, please contact:
Halma plc
Marc Ronchetti, Group Chief Executive +44 (0)1494 721111
Steve Gunning, Group Chief Financial Officer
Charles King, Head of Investor Relations +44 (0) 7776 685948
Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013
MHP
Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)20 3128 8100
A copy of this announcement, together with other information
about Halma, is available at www.halma.com.
About Halma
Halma is a global group of life-saving technology companies,
focused on growing a safer, cleaner, healthier future for everyone,
every day. Its purpose defines the three broad markets it operates
in:
-- Safety - Protecting people's safety and the environment as
populations grow, and enhancing worker safety.
-- Environment - Addressing the impacts of climate change,
pollution and waste, protecting life-critical resources and
supporting scientific research.
-- Health - Meeting the increasing demand for better healthcare
as chronic illness rises, driven by growing and ageing populations
and lifestyle changes.
It employs over 8,000 people in more than 20 countries, with
major operations in the UK, Mainland Europe, the USA and Asia
Pacific. Halma is listed on the London Stock Exchange (LON: HLMA)
and is a constituent of the FTSE 100 index.
Halma has been named as one of Britain's Most Admired Companies
for the past five years.
For more information www.halma.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACQUSSVROWURUAA
(END) Dow Jones Newswires
October 25, 2023 02:00 ET (06:00 GMT)
Halma (LSE:HLMA)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Halma (LSE:HLMA)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
